Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 28, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Forian Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 27
| |||||||
Bionano Genomics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Inhibrx, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 25
| |||||||
Forian Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 23
| |||||||
Bionano Genomics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Bionano Genomics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Inhibrx, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 25
| |||||||
Forian Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 17
| |||||||
Inhibrx, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 7
| |||||||
Inhibrx, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Bionano Genomics, Inc
|
0
|
—
|
—
|
—
|
0
|
Aug 17
| |||||||
Bionano Genomics, Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Sio Gene Therapies Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 15
| |||||||
Forian Inc.
| 5K |
—
|
—
|
∞
| 5K |
Mar 5
| |||||||
Forian Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Axovant Gene Therapies Ltd.
|
0
|
—
|
—
|
—
|
0
|
Oct 5
| |||||||
Axovant Gene Therapies Ltd.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Bionano Genomics, Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Bionano Genomics, Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Bionano Genomics, Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Webmd Health Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.